Ticker: APLS

Company: Apellis Pharmaceuticals, Inc.

Person: Cedric Francois, director, officer

Transaction date: Jan. 13, 2026

Reporting date: Jan. 15, 2026

Average share price: 22.1872

Sold 10186.0 shares for 225998.82